Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice
Background. Previous studies have demonstrated that energy failure is closely associated with cardiac injury. Doxorubicin (DOX) is a commonly used clinical chemotherapy drug that can mediate cardiac injury through a variety of mechanisms. Thyroxine is well known to play a critical role in energy gen...
Main Authors: | Yuan Wang, Shan Zhu, Hongtao Liu, Wen Wei, Yi Tu, Chuang Chen, Junlong Song, Juanjuan Li, Shengrong Sun, Changhua Wang, Zhiliang Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2019/7420196 |
Similar Items
-
Advances of LKB1-AMPK-mTOR Signaling Pathway in Tumor
by: Xia ZHANG, et al.
Published: (2011-08-01) -
A comparison of LKB1/AMPK/mTOR metabolic axis response to global ischaemia in brain, heart, liver and kidney in a rat model of cardiac arrest
by: Shohreh Majd, et al.
Published: (2018-06-01) -
Elucidating the role of Lkb1 and mTOR in adipose tissue
by: Ziye Xu, et al.
Published: (2019-01-01) -
Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway
by: Liuran Li, et al.
Published: (2021-05-01) -
MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway
by: Zhiyu Li, et al.
Published: (2021-01-01)